{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:45:48Z","timestamp":1792655148081,"version":"4.5.0"},"reference-count":91,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,7,1]],"date-time":"2013-07-01T00:00:00Z","timestamp":1372636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["30971169"],"award-info":[{"award-number":["30971169"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81170277"],"award-info":[{"award-number":["81170277"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100012269","name":"Aid Program for Science and Technology Innovative Research Team in Higher Educational Institutions of Hunan Province","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100012269","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.atherosclerosis.2013.03.013","type":"journal-article","created":{"date-parts":[[2013,3,26]],"date-time":"2013-03-26T03:00:23Z","timestamp":1364266823000},"page":"10-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: Atherogenesis and angiogenesis"],"prefix":"10.1016","volume":"229","author":[{"given":"Mi-Hua","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Han","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo-Hua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun-Lin","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu-Shan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhi-Sheng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib1","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1038\/nm.2538","article-title":"Atherosclerosis: current pathogenesis and therapeutic options","volume":"17","author":"Weber","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib2","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1093\/cvr\/cvq394","article-title":"Ischaemic heart disease in women: are there sex differences in pathophysiology and risk factors? position paper from the working group on coronary pathophysiology and microcirculation of the European Society of Cardiology","volume":"90","author":"Vaccarino","year":"2011","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib4","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMc1206011","article-title":"Comparative effectiveness of revascularization strategies","volume":"367","author":"Kirtane","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib5","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","author":"Itoh","year":"2004","journal-title":"Trends Genet"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib6","doi-asserted-by":"crossref","first-page":"3133","DOI":"10.1158\/1078-0432.CCR-06-2555","article-title":"DNA copy number gains at loci of growth factors and their receptors in salivary gland adenoid cystic carcinoma","volume":"13","author":"Vekony","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s10456-008-9089-1","article-title":"Sprouty proteins, masterminds of receptor tyrosine kinase signaling","volume":"11","author":"Cabrita","year":"2008","journal-title":"Angiogenesis"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib8","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1038\/nrc2780","article-title":"Fibroblast growth factor signalling: from development to cancer","volume":"10","author":"Turner","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib9","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib10","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mvr.2008.09.007","article-title":"VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration","volume":"77","author":"Li","year":"2009","journal-title":"Microvasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib11","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0008-6363(96)00102-2","article-title":"Localisation and differential expression of the fibroblast growth factor receptor (FGFR) multigene family in normal and atherosclerotic human arteries","volume":"32","author":"Hughes","year":"1996","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib12","doi-asserted-by":"crossref","first-page":"15694","DOI":"10.1074\/jbc.M601252200","article-title":"Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family","volume":"281","author":"Zhang","year":"2006","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib13","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1161\/01.ATV.21.2.214","article-title":"Mitogen-induced p53 downregulation precedes vascular smooth muscle cell migration from healthy tunica media and proliferation","volume":"21","author":"Rodriguez-Campos","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib14","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1172\/JCI116847","article-title":"Distinct patterns of expression of fibroblast growth factors and their receptors in human atheroma and nonatherosclerotic arteries. Association of acidic FGF with plaque microvessels and macrophages","volume":"92","author":"Brogi","year":"1993","journal-title":"J\u00a0Clin Invest"},{"issue":"Suppl. 4","key":"10.1016\/j.atherosclerosis.2013.03.013_bib15","first-page":"137","article-title":"Role of basic fibroblast growth factor and platelet-derived growth factor (B-chain) in neointima formation after arterial injury","volume":"84","author":"Lindner","year":"1995","journal-title":"Z\u00a0Kardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib16","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.atherosclerosis.2010.01.006","article-title":"Fibroblast growth factor-2 transiently activates the p53 oncosuppressor protein in human primary vascular smooth muscle cells: implications for atherogenesis","volume":"210","author":"Barillari","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib17","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1089\/adt.2009.0258","article-title":"Macrophage-mediated proteolytic remodeling of the extracellular matrix in atherosclerosis results in neoepitopes: a potential new class of biochemical markers","volume":"8","author":"Skjot-Arkil","year":"2010","journal-title":"Assay Drug Dev Technol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib18","doi-asserted-by":"crossref","first-page":"3555","DOI":"10.1161\/01.CIR.96.10.3555","article-title":"Primate smooth muscle cell migration from aortic explants is mediated by endogenous platelet-derived growth factor and basic fibroblast growth factor acting through matrix metalloproteinases 2 and 9","volume":"96","author":"Kenagy","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib19","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCRESAHA.109.206029","article-title":"TRAIL promotes VSMC proliferation and neointima formation in a FGF-2-, Sp1 phosphorylation-, and NFkappaB-dependent manner","volume":"106","author":"Chan","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib20","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1365-2613.2000.00155.x","article-title":"The extracellular matrix can regulate vascular cell migration, proliferation, and survival: relationships to vascular disease","volume":"81","author":"Raines","year":"2000","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib21","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1093\/cvr\/cvs115","article-title":"Smooth muscle cell phenotypic switching in atherosclerosis","volume":"95","author":"Gomez","year":"2012","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1152\/physrev.1995.75.3.487","article-title":"Regulation of differentiation of vascular smooth muscle cells","volume":"75","author":"Owens","year":"1995","journal-title":"Physiol Rev"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib23","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1161\/01.RES.0000216596.73005.3c","article-title":"Excitation-transcription coupling in arterial smooth muscle","volume":"98","author":"Wamhoff","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib24","doi-asserted-by":"crossref","first-page":"15980","DOI":"10.1074\/jbc.M809399200","article-title":"FRS2 via fibroblast growth factor receptor 1 is required for platelet-derived growth factor receptor beta-mediated regulation of vascular smooth muscle marker gene expression","volume":"284","author":"Chen","year":"2009","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib25","doi-asserted-by":"crossref","first-page":"e33126","DOI":"10.1371\/journal.pone.0033126","article-title":"Ghrelin attenuates the osteoblastic differentiation of vascular smooth muscle cells through the ERK pathway","volume":"7","author":"Liang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib26","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bbrc.2009.11.038","article-title":"Fibroblast growth factor-2 induces osteogenic differentiation through a Runx2 activation in vascular smooth muscle cells","volume":"394","author":"Nakahara","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000159147","article-title":"Endothelial dysfunction in atherosclerosis","volume":"33","author":"Busse","year":"1996","journal-title":"J\u00a0Vasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib28","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1083\/jcb.110.2.511","article-title":"Correlation of cell migration, cell invasion, receptor number, proteinase production, and basic fibroblast growth factor levels in endothelial cells","volume":"110","author":"Tsuboi","year":"1990","journal-title":"J\u00a0Cell Biol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib29","doi-asserted-by":"crossref","first-page":"3355","DOI":"10.1172\/JCI35298","article-title":"The FGF system has a key role in regulating vascular integrity","volume":"118","author":"Murakami","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib30","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.yjmcc.2009.01.015","article-title":"Endothelium-targeted overexpression of constitutively active FGF receptor induces cardioprotection in mice myocardial infarction","volume":"46","author":"Matsunaga","year":"2009","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib31","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1080\/08977190410001724505","article-title":"Protective effects of basic fibroblast growth factor in early atherosclerosis","volume":"22","author":"Six","year":"2004","journal-title":"Growth Factor"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib32","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/01.ATV.0000065193.27491.5B","article-title":"Low density lipoproteins interact with acidic fibroblast growth factor and modify its function","volume":"23","author":"Ananyeva","year":"2003","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib33","doi-asserted-by":"crossref","first-page":"H154","DOI":"10.1152\/ajpheart.00075.2010","article-title":"Endothelial FGF receptor signaling accelerates atherosclerosis","volume":"300","author":"Che","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib34","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1161\/01.ATV.0000227689.41288.5e","article-title":"Inhibition of fibroblast growth factor receptor signaling attenuates atherosclerosis in apolipoprotein E-deficient mice","volume":"26","author":"Raj","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib35","doi-asserted-by":"crossref","first-page":"H27","DOI":"10.1152\/ajpheart.01037.2010","article-title":"Endothelial FGF receptor signaling: angiogenic versus atherogenic effects","volume":"300","author":"Williams","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib36","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ejvs.2004.02.022","article-title":"Basic fibroblast growth factor mediates carotid plaque instability through metalloproteinase-2 and -9 expression","volume":"28","author":"Sapienza","year":"2004","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib37","doi-asserted-by":"crossref","first-page":"2436","DOI":"10.1161\/01.CIR.0000145138.25577.F1","article-title":"Angiogenesis-dependent and independent phases of intimal hyperplasia","volume":"110","author":"Khurana","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib38","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0741-5214(98)70299-X","article-title":"Antisense basic fibroblast growth factor gene transfer reduces early intimal thickening in a rabbit femoral artery balloon injury model","volume":"27","author":"Neschis","year":"1998","journal-title":"J\u00a0Vasc Surg"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib39","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1161\/01.RES.69.2.360","article-title":"Vascular response to basic fibroblast growth factor when infused onto the normal adventitia or into the injured media of the rat carotid artery","volume":"69","author":"Cuevas","year":"1991","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib40","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.atherosclerosis.2011.01.016","article-title":"Augmented angiogenesis in adventitia promotes growth of atherosclerotic plaque in apolipoprotein E-deficient mice","volume":"215","author":"Tanaka","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib41","doi-asserted-by":"crossref","first-page":"e18248","DOI":"10.1371\/journal.pone.0018248","article-title":"Carotid plaque age is a feature of plaque stability inversely related to levels of plasma insulin","volume":"6","author":"Hagg","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib42","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2261-12-7","article-title":"Effect of calcification on the mechanical stability of plaque based on a three-dimensional carotid bifurcation model","volume":"12","author":"Wong","year":"2012","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/S0167-5273(97)02921-5","article-title":"Serum basic fibroblast growth factor levels in patients with ischaemic heart disease","volume":"59","author":"Hasdai","year":"1997","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib44","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1161\/01.RES.73.3.589","article-title":"Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. An en face study","volume":"73","author":"Lindner","year":"1993","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/j.1582-4934.2010.01082.x","article-title":"Increased expression of bFGF is associated with carotid atherosclerotic plaques instability engaging the NF-kappaB pathway","author":"Sigala","year":"2010","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib46","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/01.CIR.98.12.1212","article-title":"Transfection of inducible nitric oxide synthase gene causes apoptosis in vascular smooth muscle cells","volume":"98","author":"Iwashina","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib47","doi-asserted-by":"crossref","first-page":"H2192","DOI":"10.1152\/ajpheart.00535.2009","article-title":"Regulation of reactive oxygen species by p53: implications for nitric oxide-mediated apoptosis","volume":"298","author":"Popowich","year":"2010","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib48","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3988\/jcn.2011.7.2.69","article-title":"Plaque rupture is a determinant of vascular events in carotid artery atherosclerotic disease: involvement of matrix metalloproteinases 2 and 9","volume":"7","author":"Heo","year":"2011","journal-title":"J\u00a0Clin Neurol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib49","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/CRD.0b013e3181620e50","article-title":"Therapeutic angiogenesis: a new treatment approach for ischaemic heart disease\u2013part II","volume":"16","author":"Ahn","year":"2008","journal-title":"Cardiol Rev"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib50","first-page":"264","article-title":"Angiogenesis-a novel therapeutic approach for ischaemic heart disease","volume":"18","author":"Nessa","year":"2009","journal-title":"Mymensingh Med J"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib51","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00395-008-0760-x","article-title":"Collateral circulation: past and present","volume":"104","author":"Schaper","year":"2009","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib52","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1172\/JCI7315","article-title":"Fibroblast growth factor-2 mediates pressure-induced hypertrophic response","volume":"104","author":"Schultz","year":"1999","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib53","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2353\/ajpath.2007.070003","article-title":"Fibroblast growth factor-2 regulates myocardial infarct repair: effects on cell proliferation, scar contraction, and ventricular function","volume":"171","author":"Virag","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib54","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ijcard.2010.07.024","article-title":"Acidic and basic fibroblast growth factors involved in cardiac angiogenesis following infarction","volume":"152","author":"Zhao","year":"2011","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib55","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1161\/CIRCULATIONAHA.110.010264","article-title":"Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure","volume":"124","author":"Banquet","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib56","doi-asserted-by":"crossref","first-page":"12140","DOI":"10.1073\/pnas.0704966104","article-title":"Combinatorial protein therapy of angiogenic and arteriogenic factors remarkably improves collaterogenesis and cardiac function in pigs","volume":"104","author":"Lu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib57","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1089\/ten.tea.2010.0551","article-title":"Sequential delivery of basic fibroblast growth factor and platelet-derived growth factor for angiogenesis","volume":"17","author":"Tengood","year":"2011","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib58","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/j.biomaterials.2010.10.048","article-title":"A\u00a0bioactive self-assembled membrane to promote angiogenesis","volume":"32","author":"Chow","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib59","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1631\/jzus.B1000302","article-title":"Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model","volume":"11","author":"Nie","year":"2010","journal-title":"J\u00a0Zhejiang Univ Sci B"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib60","doi-asserted-by":"crossref","first-page":"13444","DOI":"10.1073\/pnas.1110121108","article-title":"Injectable fibroblast growth factor-2 coacervate for persistent angiogenesis","volume":"108","author":"Chu","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib61","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1089\/ten.tea.2009.0828","article-title":"Development of functional fibrous matrices for the controlled release of basic fibroblast growth factor to improve therapeutic angiogenesis","volume":"16","author":"Kim","year":"2010","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib62","doi-asserted-by":"crossref","first-page":"9320","DOI":"10.1016\/j.biomaterials.2010.08.058","article-title":"Heparinized chitosan\/poly(gamma-glutamic acid) nanoparticles for multi-functional delivery of fibroblast growth factor and heparin","volume":"31","author":"Tang","year":"2010","journal-title":"Biomaterials"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib63","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1016\/j.biomaterials.2010.11.075","article-title":"Delivery of basic fibroblast growth factor with a pH-responsive, injectable hydrogel to improve angiogenesis in infarcted myocardium","volume":"32","author":"Garbern","year":"2011","journal-title":"Biomaterials"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0008-6363(02)00708-3","article-title":"Biological activities of fibroblast growth factor-2 in the adult myocardium","volume":"57","author":"Detillieux","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib65","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.1991.tb49035.x","article-title":"Basic fibroblast growth factor in cultured cardiac myocytes","volume":"638","author":"Kardami","year":"1991","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib66","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.yjmcc.2006.10.005","article-title":"The cardioprotective effect of the low molecular weight isoform of fibroblast growth factor-2: the role of JNK signaling","volume":"42","author":"Liao","year":"2007","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib67","doi-asserted-by":"crossref","first-page":"H1071","DOI":"10.1152\/ajpheart.00290.2001","article-title":"Acute protection of ischaemic heart by FGF-2: involvement of FGF-2 receptors and protein kinase C","volume":"282","author":"Jiang","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib68","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.cardiores.2004.01.009","article-title":"Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion","volume":"62","author":"Jiang","year":"2004","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib69","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1139\/Y09-049","article-title":"High molecular weight FGF-2 promotes postconditioning-like cardioprotection linked to activation of protein kinase C isoforms, as well as Akt and p70 S6 kinases. [corrected]","volume":"87","author":"Jiang","year":"2009","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib70","doi-asserted-by":"crossref","first-page":"3140","DOI":"10.1161\/01.CIR.0000105723.91637.1C","article-title":"Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischaemia","volume":"108","author":"House","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib71","doi-asserted-by":"crossref","first-page":"H2167","DOI":"10.1152\/ajpheart.00392.2005","article-title":"Cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2 is mediated by the MAPK cascade","volume":"289","author":"House","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib72","doi-asserted-by":"crossref","first-page":"H354","DOI":"10.1152\/ajpheart.00804.2006","article-title":"The protein kinase C pathway mediates cardioprotection induced by cardiac-specific overexpression of fibroblast growth factor-2","volume":"293","author":"House","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib73","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1248\/bpb.33.444","article-title":"Cardiac protection by basic fibroblast growth factor from ischaemia\/reperfusion-induced injury in diabetic rats","volume":"33","author":"Xiao","year":"2010","journal-title":"Biol Pharm Bull"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib74","doi-asserted-by":"crossref","DOI":"10.3109\/08977194.2012.656759","article-title":"Fibroblast growth factor-2-induced cardioprotection against myocardial infarction occurs via the interplay between nitric oxide, protein kinase signaling, and ATP-sensitive potassium channels","author":"Manning","year":"2012","journal-title":"Growth Factor"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib75","first-page":"783","article-title":"The stimulation of neoangiogenesis in the ischemic human heart by the growth factor FGF: first clinical results","volume":"39","author":"Schumacher","year":"1998","journal-title":"J\u00a0Cardiovasc Surg (Torino)"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib76","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1161\/01.CIR.100.18.1865","article-title":"Local perivascular delivery of basic fibroblast growth factor in patients undergoing coronary bypass surgery: results of a phase I randomized, double-blind, placebo-controlled trial","volume":"100","author":"Laham","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib77","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0003-4975(98)00340-3","article-title":"Therapeutic angiogenesis with basic fibroblast growth factor: technique and early results","volume":"65","author":"Sellke","year":"1998","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib78","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1067\/mtc.2002.121974","article-title":"Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein","volume":"124","author":"Ruel","year":"2002","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib79","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1016\/S0735-1097(00)00988-8","article-title":"Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: results of a phase I open-label dose escalation study","volume":"36","author":"Laham","year":"2000","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib80","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1016\/S0002-9149(00)00787-6","article-title":"Effects of a single intracoronary injection of basic fibroblast growth factor in stable angina pectoris","volume":"85","author":"Unger","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib81","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1161\/hc0802.104407","article-title":"Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial","volume":"105","author":"Simons","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib82","first-page":"174","article-title":"The value of angiogenic therapy with intramyocardial administration of basic fibroblast growth factor to treat severe coronary artery disease","volume":"16","author":"Katayama","year":"2010","journal-title":"Ann Thorac Cardiovasc Surg"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib83","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.ahj.2010.11.023","article-title":"Intramyocardial plasmid-encoding human vascular endothelial growth factor A165\/basic fibroblast growth factor therapy using percutaneous transcatheter approach in patients with refractory coronary artery disease (VIF-CAD)","volume":"161","author":"Kukula","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib84","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1161\/01.CIR.0000132468.82942.F5","article-title":"Janus phenomenon: the interrelated tradeoffs inherent in therapies designed to enhance collateral formation and those designed to inhibit atherogenesis","volume":"109","author":"Epstein","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/427863","article-title":"Clinical application of mesenchymal stem cells in the treatment and prevention of graft-versus-host disease","volume":"2011","author":"Lin","year":"2011","journal-title":"Adv Hematol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib86","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1093\/ejechocard\/jeq116","volume":"12","author":"Beitnes","year":"2011","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib87","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ejheart.2007.06.012","article-title":"Combined therapy with human cord blood cell transplantation and basic fibroblast growth factor delivery for treatment of myocardial infarction","volume":"9","author":"Cho","year":"2007","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib88","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jacc.2011.06.016","article-title":"10 years of intracoronary and intramyocardial bone marrow stem cell therapy of the heart: from the methodological origin to clinical practice","volume":"58","author":"Strauer","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib89","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.108.184622","article-title":"The antiangiogenic activity of rPAI-1(23) inhibits vasa vasorum and growth of atherosclerotic plaque","volume":"104","author":"Drinane","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib90","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1002\/jcb.10721","article-title":"Induction of stromelysin-1 (MMP-3) by fibroblast growth factor-2 (FGF-2) in FGF-2\u2212\/\u2212 microvascular endothelial cells requires prolonged activation of extracellular signal-regulated kinases-1 and -2 (ERK-1\/2)","volume":"90","author":"Pintucci","year":"2003","journal-title":"J\u00a0Cell Biochem"},{"key":"10.1016\/j.atherosclerosis.2013.03.013_bib91","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/01.CIR.102.14.1605","article-title":"Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease","volume":"102","author":"Udelson","year":"2000","journal-title":"Circulation"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915013001895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,7]],"date-time":"2020-05-07T09:00:16Z","timestamp":1588842016000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915013001895"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":91,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S0021915013001895"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.03.013","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Janus-like role of fibroblast growth factor 2 in arteriosclerotic coronary artery disease: Atherogenesis and angiogenesis","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2013.03.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}